Benefits
Bioactive Coenzyme Form
P-5-P is the coenzyme form of B6. When swallowed, it is dephosphorylated in the gut and absorbed as free vitamin B6, so it does not skip the body's own phosphorylation step. Healthy adults turn pyridoxine into the same active form. An advantage for people with impaired B6 conversion, such as some liver conditions or genetic variants, is a hypothesis rather than a trial finding.
Neurotransmitter Synthesis
As PLP, vitamin B6 is the cofactor for the enzymes that make serotonin (from 5-HTP), dopamine (from L-DOPA), GABA (from glutamate) and histamine (from histidine). This explains why B6 deficiency can affect mood and nerve function. It does not show that extra B6 lifts mood in people who already get enough.
Premenstrual symptoms (PMS)
In a systematic review of nine placebo-controlled trials (940 women), vitamin B6 at up to 100 mg/day was more likely than placebo to ease overall premenstrual symptoms and premenstrual low mood, but most were small trials of low quality. In one crossover trial, 50 mg/day helped emotional symptoms only. These trials used pyridoxine, not P-5-P.
Morning sickness in early pregnancy
In a 342-woman placebo-controlled trial, 30 mg/day pyridoxine for five days eased nausea in early pregnancy, though the drop in vomiting was not statistically significant. Trials of B6 alone have had mixed results, and a systematic review rated the evidence as low quality. ACOG suggests B6 as a first step under a doctor's care. The trials used pyridoxine, not P-5-P.
Homocysteine Lowering
As PLP, B6 is the cofactor for cystathionine beta-synthase, which clears homocysteine. Adequate B6, folate and B12 help keep homocysteine in the normal range. Lowering this marker is not the same as fewer heart events: a review of 15 randomized trials of B-vitamin homocysteine lowering found no effect on heart attacks or deaths and a small drop in stroke.
Mechanism of action
Coenzyme for more than 100 enzyme reactions
PLP is the cofactor for amino acid transaminases (including ALT and AST, measured in liver blood tests), amino acid decarboxylases (neurotransmitter synthesis), glycogen phosphorylase (glycogen breakdown), delta-aminolevulinate synthase (heme synthesis), cystathionine beta-synthase (homocysteine metabolism) and kynureninase (tryptophan breakdown).
Absorption and activation
Phosphorylated B6 forms, including P-5-P, are dephosphorylated in the gut and absorbed as free vitamin by passive diffusion. Cells then use pyridoxal kinase to add the phosphate back, so swallowed P-5-P and pyridoxine end up as the same active coenzyme.
Neurotransmitter Decarboxylase Cofactor
Needed to turn 5-HTP into serotonin, L-DOPA into dopamine, glutamate into GABA and histidine into histamine. B6 deficiency can impair these pathways together.
Heme Synthesis
PLP is the cofactor for delta-aminolevulinate synthase, the first and rate-limiting step of heme synthesis, which helps explain why B6 deficiency is linked to small-red-cell (microcytic) anemia.
Clinical trials
Randomized, double-blind, placebo-controlled crossover trial of pyridoxine 50 mg/day, three months on each treatment (Doll et al. 1989, J R Coll Gen Pract)
63 women aged 18 to 49 with moderate to severe premenstrual symptoms; 32 completed all seven months.
Pyridoxine significantly eased emotional symptoms (depression, irritability and tiredness) compared with placebo. It had no significant effect on physical or menstrual-type symptoms, and a strong placebo response complicated the results. The trial used pyridoxine, not P-5-P.
Randomized, double-blind, placebo-controlled trial of pyridoxine hydrochloride 30 mg/day for 5 days (Vutyavanich et al. 1995, Am J Obstet Gynecol)
342 women at 17 weeks of pregnancy or earlier at a university antenatal clinic in Thailand.
Nausea scores fell significantly more with pyridoxine than with placebo (p = 0.0008). Vomiting episodes also fell more, but the difference was not statistically significant (p = 0.0552). The trial used pyridoxine, not P-5-P.